SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?


To: MarcG who wrote (600)11/16/1998 11:47:00 AM
From: Bart Goemaere  Read Replies (1) | Respond to of 857
 
Personaly I think they will get the first approval in Europe.
Afterwards we can expect approval by the FDA.
Directly after approval we can see the stocks value explode because
then some institutional investors will invest in it.

If, on the other hand Ampligen doesn't get approved, then we longs
are having a serious problem !

Which interpretations do you make about some statements ? I can't find
any negative things !